Clinical Trial Update: Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intralesional bevacizumab injections for keloids was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Tirgan, Michael H., M.D. | Conditions: Keloid | Phase 2 | Status: TERMINATED